ArticleClinical and experimental medicine2025

LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway.

Yue Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.